Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
1,755,840
-
Shares change
-
+429,693
-
Total reported value, excl. options
-
$65,417,636
-
Value change
-
+$16,203,717
-
Put/Call ratio
-
40.7%
-
Number of buys
-
28
-
Number of sells
-
-12
-
Price
-
$37.27
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q2 2018
54 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q2 2018.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,755,840 shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (411,993 shares), UBS Group AG (371,065 shares), BAROMETER CAPITAL MANAGEMENT INC. (210,900 shares), MORGAN STANLEY (154,059 shares), WELLS FARGO & COMPANY/MN (139,554 shares), RAYMOND JAMES & ASSOCIATES (117,304 shares), NTV Asset Management LLC (51,450 shares), LPL Financial LLC (33,222 shares), CITADEL ADVISORS LLC (28,286 shares), and ROYAL BANK OF CANADA (25,600 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.